Navigation Links
Canadian Government Announces Funding for Leading Biotechnology Firm's Project
Date:3/6/2009

Performance Plants to Further Develop Plant Traits for Biofuel

KINGSTON, ON, March 6 /PRNewswire/ - Performance Plants Inc. (PPI), a global leader in agricultural and biofuel biotechnology development and Sustainable Development Technology Canada (SDTC) are pleased to announce that a project led by PPI will be receiving up to $5,565,063 in funding from SDTC. The funds will be used to advance its trait technologies that improve conversion of cellulose into cost-effective biofuels and biochemicals.

The announcement was made today by Natural Resources Minister Lisa Raitt and Vicky Sharpe, SDTC President and Chief Executive Officer.

"The support of SDTC is important and greatly appreciated as it validates the efficacy of our technologies to more efficiently convert non-food biomass into cellulosic ethanol," says Peter Matthewman, President, Performance Plants. "We believe our technologies are the critical link to developing a profitable and sustainable clean energy sector that replaces such feedstocks as coal and petroleum with non-food biomass crops."

According to Matthewman, the challenge has been breaking down cellulose - tight chains of indigestible sugar molecules that make up the majority of plant cell walls - for conversion into renewable sources of energy. PPI has discovered a family of technologies called Enhanced Conversion Technology(TM) (ECT(TM)) that alter plant cell walls to significantly improve their conversion into biofuels.

The primary use of the SDTC funding will be to develop ECT(TM) to improve the amount of releasable glucose and develop these traits in non-food crops to increase their conversion efficiency. The SDTC funding support will also be used to support the acceleration of Performance Plants' Biomass Enhancement(TM) (BET(TM)) and Water Use Efficiency(TM) (WET(TM)) technologies. These yield stabilization technologies will be combined (stacked) with ECT(TM) to further reduce costs by significantly increasing feedstock yield per hectare of land.

These traits are just some of the technologies developed by the company, which include Yield Protection Technology(R) (YPT(R)) and other traits that stabilize seed yields in drought and heat conditions and improve seed size.

"Current assessments for the North American biofuels market indicate that over 1 billion tons of dry biomass per year will be required to switch current petroleum consumption to 30% renewable fuels," says Mr. Matthewman. "Non-food purpose grown energy crops can provide the yield per hectare necessary to sustainably and cost-efficiently support a new clean energy industrial sector."

PPI's next generation of non-food biofuel crops will also provide benefits to farmers by providing alternative crops such as switch grass, Miscanthus, sorghum and hemp that can be grown on marginal land with limited fertilizer and water requirements.

This next generation biofuel conversion technologies will be driven by PPI trait improvements have the potential to offer the necessary solutions for Canada to create a viable, profitable new clean energy industrial sector that use reliable, consistent, non-food feedstocks with superior processing characteristics, according to Mr. Matthewman. PPI is currently working with its partners to enable the value chain that will see these improvements brought to commercial reality.

    About Sustainable Development Technology Canada (SDTC)
    ------------------------------------------------------

Sustainable Development Technology Canada (SDTC) is an arm's-length foundation which has received $1.05 billion from the Government of Canada as part of its commitment to create a healthy environment and a high quality of life for all Canadians.

SDTC operates two funds aimed at the development and demonstration of innovative technological solutions. The $550 million SD Tech Fund(TM) supports projects that address climate change, air quality, clean water and clean soil. The $500 million NextGen Biofuels Fund(TM) supports the establishment of first-of-kind large demonstration-scale facilities for the production of next-generation renewable fuels.

SDTC operates as a not-for-profit corporation and has been working with the public and private sector including industry, academia, non-governmental organizations (NGOs), the financial community and all levels of government to achieve this mandate.

    About Performance Plants Inc. (PPI)
    -----------------------------------

Performance Plants Inc. (PPI) (www.performanceplants.com) is a global leader in agricultural and biofuel technology development. The company's patented technologies weatherproof food and non-food biofuel crops through periods of drought and heat stress resulting in more abundant, consistent and cost-effective harvests for farmers, and feedstock suppliers. The company has licensed its breakthrough Yield Protection Technology(R) to some of the world's leading seed companies such as Syngenta, Stine, RiceTec and Scotts Miracle Gro. Headquartered in Kingston, Ontario, the privately-held company has research and development facilities in Kingston, Saskatoon, and Waterloo, New York.

This Canadian based firm is actively growing non-food biofuel crops to replace coal at Lafarge Canada Inc.'s cement plant in Bath, ON. PPI and Lafarge have a multi-year agreement to develop and grow clean energy biomass.


'/>"/>
SOURCE Performance Plants Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. The Government of Quebec and the New Canadian Government Invest in the Creation of an International Biobank
2. Oncolytics Biotech Inc. Announces Issuance of 8th Canadian Patent
3. Kiwa Bio-Tech Products Group Discusses Cooperative Efforts With Canadian Agricultural Ministry and Canadian Company
4. BioElectronics Announces Canadian Retail Product Launch
5. CSL Behring Signs Agreements With Canadian Blood Services and Hema-Quebec to Supply Life-Saving Therapies
6. Canadian Centre for DNA Barcoding to Participate in Microchip Biotechnologies Early Access Program for Microchip-Based DNA Sample Preparation and Cycle Sequencing
7. Boston Scientific Receives Canadian Approval for TAXUS(R) Liberte(R) Stent System
8. Angiotechs Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System
9. Oncolytics Biotech Inc. Announces Issuance of 9th Canadian Patent
10. New discoveries, new labs highlight international Canadian Light Source meeting
11. Aortic Stent Grafts Will Boost Canadian and Japanese Peripheral Vascular Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/21/2017)... ... 2017 , ... During HIMSS 2017, CloudMine, a secure, cloud-based ... partnership with Redox, a leader in cloud-based healthcare integration and API services. The ... data secure in the cloud. , The digital health developers, and various healthcare ...
(Date:2/21/2017)... , ... February 21, 2017 , ... The medical potential ... their use, in multiple areas of medicine, due to their differentiating characteristics. Stem cells ... they have the ability to be induced to become tissue or organic-specific cells with ...
(Date:2/21/2017)... VANCOUVER, British Columbia , Feb. 21, 2017 /PRNewswire/ ... that apatorsen results from two randomized Phase 2 clinical trials ... 2017 Genitourinary Cancers Symposium, held February 16 th - 18 ... from trials in bladder and prostate cancers demonstrated apatorsen was ... standard-of-care treatments. ...
(Date:2/21/2017)... , Feb. 21, 2017   Invitae Corporation ... information companies, today announced that members of the company,s ... 37th Annual Health Care Conference on Monday, March 6, ... Pacific in Boston, Massachusetts . ... may be accessed by visiting the investors section of ...
Breaking Biology Technology:
(Date:2/16/2017)... 16, 2017  Genos, a community for personal ... has received Laboratory Accreditation from the College of ... to laboratories that meet stringent requirements around quality, ... processes. "Genos is committed to maintaining ... We,re honored to be receiving CAP accreditation," said ...
(Date:2/10/2017)... Feb 10, 2017 Research and ... "Personalized Medicine - Scientific and Commercial Aspects" to ... ... Diagnosis is integrated with therapy for selection of treatment as ... detection and prevention of disease in modern medicine. Biochip/microarray technologies ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global ... reach $11.4 billion by 2021, growing at a compound annual ... - An overview of the global markets for synthetic biology. ... estimates for 2016, and projections of compound annual growth rates ...
Breaking Biology News(10 mins):